Menu Search
Equities

Astrana Health Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
3AM:MUN

Astrana Health Inc

Actions
  • Price (EUR)18.50
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change-47.74%
  • Beta0.9120
Data delayed at least 15 minutes, as of Feb 06 2026 07:06 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Astrana Health, Inc. is a physician-centric, artificial intelligence (AI)-powered healthcare company focused on delivering patient-centered care. The Company provides care coordination services to each major constituent of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The Company's segments include Care Partners, Care Delivery, and Care Enablement. Its Care Partners segment is focused on building and managing provider networks by partnering with, empowering, and investing in provider partners aligned on a shared vision for coordinated care delivery. Its Care Delivery organization includes primary care, multi-specialty care, and ancillary care services. Its Care Enablement segment represents a comprehensive platform that integrates clinical, operational, financial, and administrative information. It supports more than 20,000 providers.

  • Revenue in USD (TTM)2.90bn
  • Net income in USD9.54m
  • Incorporated2008
  • Employees1.90k
  • Location
    Astrana Health Inc1668 S. Garfield Avenue, 2Nd FloorALHAMBRA 91801United StatesUSA
  • Phone+1 (626) 282-0288
  • Fax+1 (818) 839-5190
  • Websitehttps://www.astranahealth.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.